Executive Summary
The plaintiff, Novartis Ag, filed a suit alleging infringement of its patent (IN 233161) concerning the drug Eltrombopag Olamine. The court found a clear prima facie case in favor of the plaintiff, noting that the rights to the patent had been confirmed previously.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court - Orders. Understanding the court's reasoning in Novartis Ag vs Medipol Pharmaceuticals India Pvt Ltd is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Novartis AgvsMsn Laboratories Pvt Ltd
The plaintiff alleges that the defendant infringed its patent by launching a product containing Eltrombopag Olamine without a license. The court granted an ex parte injunction against the defendant's product 'REBOPAG'.
Mr Amit Arora Sole Proprietor M/S Hydro ValvesvsThe Controller General Of Patents Design and Trade Marks & Ors.
The petitioner filed Rectification Petitions seeking cancellation of three 'MILTON' trademarks registered in Class 21. Respondents raised a preliminary objection regarding the pendency of earlier related rectification petitions before the Trade Marks Registry, Mumbai. The court satisfied this objection after the petitioner undertook to withdraw the relevant pending petitions.
Corcept Therapeutics IncorporatedvsThe Deputy Controller Of Patents And Designs
Corcept Therapeutics Incorporated filed an appeal against the Assistant Controller's order refusing to grant a patent for Indian Patent Application No. 202117031510. The appellant contends that the refusal was erroneous as the application meets all criteria for patentability, while the respondent argued it failed tests under Sections 2(1)(j), 2(1)(ja), and 3(e)/3(i) of the Patents Act.
The Polo/Lauren Company L.P.vsAbhinav Mehta And Anr.
In this trademark dispute before the Delhi High Court, the court addressed procedural matters concerning an undertaking filed by the respondent. Since the crucial undertaking was not placed on record and the petitioner had not received a copy, the judge directed the parties to coordinate documentation. Consequently, the hearing was re-notified for June 1, 2023, allowing both sides time to ensure all necessary documents are properly presented.
Under Armour Inc.vsAshwani & Anr.
In this ongoing trademark litigation, the Delhi High Court issued procedural orders to advance the case. The court directed that notice be served on all parties and set a returnable date for July 2023. Crucially, the court allowed an application seeking access to the official records of Trademark Registration No. 5372621 in Class 25, ensuring these documents would be placed before the court for consideration.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.